The justices heard oral arguments on whether the FDA overstepped its authority when giving more people access to the so-called abortion drug mifepristone
Johns Hopkins expert Suzanne Bell explains the possible reproductive health impacts of limiting access to a pill that has been safely used by millions of people
Suzanne Bell, PhD, of the Johns Hopkins Bloomberg School of Public Health is available to comment on the safety of mifepristone and the impact of restricting ac